Aksocol Chemicals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 M
- Revenue Growth 2112.27%
- Profit Growth -705.71%
- Ebitda 177.89%
- Net Worth -39.61%
- Total Assets 178.87%
About Aksocol Chemicals
Aksocol Chemicals Private Limited (ACPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 March 2018 (Six years and 11 months 20 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹4.00 M.
Ashok Solanki, Shashank Solanki, and Chirag Solanki serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24304MH2018PTC306146
- Company No.
306146
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Mar 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Aksocol Chemicals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shashank Solanki  | Director | 01-Aug-2018 | Current |
| Ashok Solanki | Director | 08-Mar-2018 | Current |
| Chirag Solanki | Director | 04-Oct-2021 | Current |
Financial Performance of Aksocol Chemicals.
Aksocol Chemicals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 2112.27% increase. The company also saw a substantial fall in profitability, with a 705.71% decrease in profit. The company's net worth observed a substantial decline by a decrease of 39.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aksocol Chemicals?
In 2019, Aksocol Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 May 2024 | Hdfc Bank Limited | ₹4.00 M | Open |
How Many Employees Work at Aksocol Chemicals?
Unlock and access historical data on people associated with Aksocol Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aksocol Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aksocol Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
